| Patient-derived xenografts and organoids model therapy response in prostate cancer S Karkampouna, F La Manna, A Benjak, M Kiener, M De Menna, E Zoni, ... Nature communications 12 (1), 1117, 2021 | 64 | 2021 |
| Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens R Servant, M Garioni, T Vlajnic, M Blind, H Pueschel, DC Müller, ... The journal of pathology 254 (5), 543-555, 2021 | 27 | 2021 |
| The dilemma of HER2 double-equivocal breast carcinomas: genomic profiling and implications for treatment C Marchiò, P Dell’Orto, L Annaratone, FC Geyer, T Venesio, E Berrino, ... The American journal of surgical pathology 42 (9), 1190, 2018 | 21 | 2018 |
| Diagnostic targeted sequencing panel for hepatocellular carcinoma genomic screening V Paradiso, A Garofoli, N Tosti, M Lanzafame, V Perrina, L Quagliata, ... The Journal of Molecular Diagnostics 20 (6), 836-848, 2018 | 17 | 2018 |
| Alterations in homologous recombination repair genes in prostate cancer brain metastases A Rodriguez-Calero, J Gallon, D Akhoundova, S Maletti, A Ferguson, ... Nature Communications 13 (1), 2400, 2022 | 12 | 2022 |
| PipeIT: a singularity container for molecular diagnostic somatic variant calling on the ion torrent next-generation sequencing platform A Garofoli, V Paradiso, H Montazeri, PM Jermann, G Roma, L Tornillo, ... The journal of molecular diagnostics 21 (5), 884-894, 2019 | 11 | 2019 |
| Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members M Coto‐Llerena, N Tosti, S Taha‐Mehlitz, V Kancherla, V Paradiso, ... Hepatology communications 5 (4), 661-674, 2021 | 10 | 2021 |
| The genomic landscape of prostate cancer brain metastases A Rodriguez, J Gallon, D Akhoundova, S Maletti, A Ferguson, J Cyrta, ... BioRxiv, 2020.05. 12.092296, 2020 | 5 | 2020 |
| Identification of somatic mutations in thirty-year-old serum cell-free DNA from patients with breast cancer: a feasibility study M Ritter, V Paradiso, P Widmer, A Garofoli, L Quagliata, ... Clinical breast cancer 20 (5), 413-421. e1, 2020 | 4 | 2020 |
| The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas L Tornillo, FS Lehmann, A Garofoli, V Paradiso, CKY Ng, S Piscuoglio Frontiers in oncology 11, 668466, 2021 | 2 | 2021 |
| PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data D Schnidrig, A Garofoli, A Benjak, G Rätsch, MA Rubin, S Piscuoglio, ... Genomics 115 (2), 110587, 2023 | | 2023 |
| PipeIT2: Somatic Variant Calling Workflow for Ion Torrent Sequencing Data A Garofoli, D Schnidrig, CKY Ng Variant Calling: Methods and Protocols, 195-204, 2022 | | 2022 |
| Development of novel prostate cancer patient-derived models and applications for translational research R Servant, M Garioni, T Vlajnic, H Pueschel, DC Müller, T Zellweger, ... European Urology Open Science 32, S173, 2021 | | 2021 |
| Computational approaches to improve precision oncology A Garofoli University_of_Basel, 2021 | | 2021 |
| Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability S Karkampouna, F La Manna, MR De Filippo, M De Menna, E Zoni, ... European Urology Open Science 19, e1822-e1823, 2020 | | 2020 |
| Patient-derived xenograft and organoids models of prostate cancer S Karkampouna, F la Manna, MR De Filippo, M Kiener, M De Menna, ... CANCER RESEARCH 80 (11), 64-64, 2020 | | 2020 |
| Abstract B18: Patient-derived xenograft and organoids models of prostate cancer S Karkampouna, F la Manna, MR De Filippo, M Kiener, M De Menna, ... Cancer Research 80 (11_Supplement), B18-B18, 2020 | | 2020 |
| PD59-07 PERSONALISED ORGANOID DRUG TREATMENT AND THERAPY RESISTANCE ON NOVEL EARLY ONSET METASTASIS XENOGRAFT MODEL S Karkampouna, F La Manna, MR De Filippo, M De Menna, E Zoni, ... The Journal of Urology 203 (Supplement 4), e1207-e1207, 2020 | | 2020 |
| Cost-effective target sequencing panel for hepatocellular carcinoma mutational screening V Paradiso, A Garofoli, N Tosti, V Perrina, M Lanzafame, L Quagliata, ... Journal of Hepatology 68, S680, 2018 | | 2018 |
